查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
组合药物诊断市场，按产品类型、按应用、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1397092

组合药物诊断市场，按产品类型、按应用、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Combination Drugs Diagnostic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，组合药物诊断市场规模为 1,743.53 万美元，2023 年至 2030 年复合CAGR为 9.2%。

组合药物诊断市场-市场动态

预计市场成长将由老年人数量的增加和诊断技术的进步推动。

人口老化需要更全面的医疗保健解决方案，解决这个问题的一种方法是透过结合诊断功能的组合药物。这些药物提供了管理老年人健康的整体方法。世界卫生组织预测，到2030年，全球每6人中就有1人年龄在60岁或以上，导致60岁以上人口从2020年的10亿增加到14亿。诊断学的进步可以及早发现疾病和病症，从而能够及时干预并在疾病的最早阶段开始联合药物治疗。然而，随着远距医生预约、患者监护和远距医疗服务的采用，COVID-19 大流行也导致了这一增长。智慧型手机用户数量不断增加，目前已超过 30 亿，预计到 2023 年将超过 40 亿，进一步推动了医疗保健应用程式的普及。此外，医疗技术统计数据表明，目前有五分之一的美国人使用健身追踪器或智慧手錶，预计到2025 年这一数字将增加20%。医疗技术和药物开发的这些进步为创造创新组合药物提供了机会。然而，制定包含诊断成分的组合药物的报销政策可能会带来挑战。

组合药物诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球组合药物诊断市场在预测期内（2023-2030 年）每年将以 9.2% 左右的CAGR成长

由于可支配收入的增加和对组合药物认识的提高，预计组合药物诊断行业将大幅成长。

根据产品类型细分，预计抗菌导管将在 2022 年占据最大市场份额

从应用细分来看，传染病是2022年的主导类型

按地区划分，北美是 2022 年的主要收入来源

组合药物诊断市场-細項分析：

全球组合药物诊断市场根据产品类型、应用和地区进行细分。

市场依产品类型分为三类：超音波、抗菌导管、心血管导管、泌尿导管、血氧测定导管、骨移植替代品、Porfimer钠和类固醇、洗脱电极。目前市场以抗菌导管为主。然而，提供诊断、合併药物治疗和抗菌导管等综合解决方案的公司或许能够解决医疗保健中感染预防的复杂问题并抓住潜在机会。

根据应用，市场分为两类：传染病、心血管疾病、精神疾病和呼吸系统疾病。市场大程度受传染病的影响。事实证明，药物和诊断的结合是传染病领域的关键因素。这种综合方法有助于制定更准确、更有针对性的治疗计划，同时考虑到病原体的独特特征和个别患者的反应。

组合药物诊断市场 - 地理洞察

从地理来看，组合药物诊断市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲等多个地区。这些地区根据参与商业活动的国家进一步分类。预计组合药物诊断市场的成长将由北美主导，这主要是由于研发（R＆D）业务投资的增加。北美，尤其是美国，被公认为全球製药和生物技术研发中心。对研发业务的大量投资有助于开发包含诊断成分的创新组合药物。根据美国国家科学基金会下属的国家科学与工程统计中心 (NCSES) 的数据，2020 年美国研发活动总支出达到 7,170 亿美元。由于盛行率上升，欧洲占据第二大市场份额癌症、心臟病和糖尿病等慢性疾病。

组合药物诊断市场-竞争格局：

组合药物诊断的市场格局一直在动态变化，许多公司为指导组合药物治疗的诊断工具的进步和商业化做出了贡献。製造商积极参与开发支持联合药物疗法的诊断方法。在临床环境中引入的新一代标靶治疗的很大一部分要求患者接受治疗适应症所需的基本测试，即伴随诊断。此外，还有一些称为补充诊断的测试可以支持治疗决策，但在处方前并不是必要的。製药公司开发新药方式的这种转变导致寻求监管部门批准的药物诊断组合数量显着增加。个人化医疗的日益增长的趋势，即根据患者个别特征制定治疗决策，是组合药物诊断市场的主要驱动力。持续的技术进步，特别是诊断技术和成像技术的进步，在塑造竞争格​​局方面发挥着至关重要的作用。

最近的发展：

罗氏的 Columvi 已获得 FDA 批准为瀰漫性大 B 细胞淋巴瘤（一种血癌）的第三线治疗药物。这种新药现在将与艾伯维 (AbbVie) 的 Epkinly 竞争，后者最近被批准用于相同的病症。罗氏新药的批准为患者提供了另一种治疗选择。

目录

第 1 章：组合药物诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的组合药物诊断市场片段
    • 组合药物诊断市场片段（按应用）
    • 按国家/地区分類的组合药物诊断市场片段
    • 按地区分類的组合药物诊断市场片段
  • 竞争洞察

第 3 章：组合药物诊断主要市场趋势

  • 组合药物诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 组合药物诊断市场限制
    • 市场限制影响分析
  • 组合药物诊断市场机会
  • 组合药物诊断市场未来趋势

第 4 章：组合药物诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：组合药物诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：组合药物诊断市场格局

  • 2022 年组合药物诊断市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：组合药物诊断市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 超音波
    • 抗菌导管
    • 心血管导管
    • 泌尿导管
    • 血氧测定导管
    • 骨移植替代品
    • 卟啉钠和类固醇
    • 洗脱电极

第 8 章：组合药物诊断市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 传染性疾病
    • 心血管疾病
    • 精神疾病
    • 呼吸系统疾病

第 9 章：组合药物诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美组合药物诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲组合药物诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区组合药物诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲组合药物诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲组合药物诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 组合药物诊断产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Roche
    • Novartis International AG
    • GlaxoSmithKline plc.
    • Pfizer Inc.
    • Sanofi
    • Bristol-Myers Squibb Company
    • Johnson & Johnson
    • Eli Lilly and Company
    • Gilead Sciences, Inc.

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1863

REPORT HIGHLIGHT

The combination medications and diagnostic tools plays a crucial role in modern healthcare, particularly in the realm of personalized medicine and targeted therapies. A combination product refers to a therapeutic or diagnostic product that combines drugs, medical devices, and/or biological products. Such products typically involve at least two of these categories and sometimes encompass all three. Common examples include traditional drug-device combinations, such as a syringe pre-filled with medication, as well as co-packaged or kitted products, like a first-aid kit containing bandages and pain-relieving medications. In the healthcare field, diagnostics pertain to the identification of the nature and cause of a disease or condition. Diagnostic tools encompass various techniques, including imaging, laboratory tests, and other medical assessments.

Combination Drugs Diagnostic Market- Market Dynamics

The market growth is anticipated to be driven by the increasing number of elderly individuals and advancements in diagnostic techniques.

Aging populations necessitate more comprehensive healthcare solutions, and one approach to address this is through combination drugs that incorporate diagnostic capabilities. These drugs offer a holistic approach to managing the health of elderly individuals. The World Health Organization predicts that by 2030, 1 in 6 people worldwide will be aged 60 years or over, resulting in an increase in the population aged 60 years and over from 1 billion in 2020 to 1.4 billion. The advancement of diagnostics allows for the early detection of diseases and conditions, enabling timely intervention and the initiation of combination drug therapies at the earliest stages of illnesses. However, the COVID-19 pandemic has also contributed to this rise, with the adoption of remote doctor's appointments, patient monitoring, and telehealth services. The increasing number of smartphone users, which has surpassed 3 billion today and is projected to exceed 4 billion by 2023, has further boosted the popularity of healthcare apps. Additionally, medical technology statistics indicate that 1 in 5 Americans currently utilize fitness trackers or smartwatches, a number expected to grow by 20% by 2025. These advancements in medical technology and drug development present opportunities for the creation of innovative combination drugs. However, establishing reimbursement policies for combination drugs that include diagnostic components can pose a challenge.

Combination Drugs Diagnostic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Combination Drugs Diagnostic market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)
  • The Combination Drugs Diagnostic sector is expected to experience substantial growth as a result of an increase in disposable income and greater awareness of combination drugs.
  • Based on product type segmentation, Antimicrobial catheters were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Infectious Diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Combination Drugs Diagnostic Market- Segmentation Analysis:

The Global Combination Drugs Diagnostic Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into three categories based on product type: Ultrasound, Antimicrobial catheters, Cardiovascular catheters, urological catheters, Oximetry catheters, Bone graft substitutes, Porfimer sodium & steroid and Eluting electrodes. The market is currently dominated by antimicrobial catheters. However, companies that provide comprehensive solutions, including diagnostics, combination drug therapies, and antimicrobial catheters, may be able to tackle the intricate issues of infection prevention in healthcare and seize potential opportunities.

The market is divided into two categories based on application: Infectious Diseases, Cardiovascular Diseases, Psychiatric Disorders, and Respiratory Disorders. The market is largely influenced by Infectious Diseases. The amalgamation of drugs and diagnostics is proving to be a crucial factor in the realm of infectious diseases. This comprehensive approach facilitates more accurate and focused treatment plans, taking into account the unique features of pathogens and individual patient reactions.

Combination Drugs Diagnostic Market- Geographical Insights

Geographically, the market for Combination Drugs Diagnostics is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The growth of the Combination Drugs Diagnostic market is expected to be dominated by North America, primarily due to the increasing investments in research and development (R&D) operations. North America, especially the United States, is recognized as a global center for pharmaceutical and biotechnology R&D. The substantial investments in R&D operations contribute to the development of innovative combination drugs that incorporate diagnostic components. According to the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation, the total expenditure on R&D activities in the United States reached USD 717.0 billion in 2020. Europe holds the second-largest market share, driven by the rising prevalence of chronic diseases such as cancer, heart disease, and diabetes.

Combination Drugs Diagnostic Market- Competitive Landscape:

The landscape of the market for combination drug diagnostics has been dynamic, with numerous companies contributing to the advancement and commercialization of diagnostic tools for guiding combination drug therapies. The manufacturers are actively involved in developing diagnostics that support combination drug therapies. A significant portion of the new generation of targeted therapies being introduced in clinical settings require patients to undergo essential tests that are necessary for the therapy's indication, known as companion diagnostics. Additionally, there are tests known as complementary diagnostics that support treatment decisions but are not essential prior to prescription. This shift in the way pharmaceutical companies develop new medicines has led to a significant increase in the number of drug-diagnostic combinations seeking regulatory approval. The growing trend towards personalized medicine, where treatment decisions are tailored to individual patient characteristics, is a major driving force in the combination drugs diagnostic market. Ongoing technological advancements, particularly in diagnostic technologies and imaging, play a crucial role in shaping the competitive landscape.

Recent Developments:

Roche's Columvi has been granted FDA approval as a third-line treatment for diffuse large B-cell lymphoma, a type of blood cancer. This new drug will now compete with AbbVie's Epkinly, which was recently approved for the same condition. The approval of Roche's new drug provides patients with another therapeutic option.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche
  • Novartis International AG
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • Eli Lilly and Company
  • Gilead Sciences, Inc.

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY PRODUCT TYPE

  • Ultrasound
  • Antimicrobial catheters
  • Cardiovascular catheters
  • Urological catheters
  • Oximetry catheters
  • Bone graft substitutes
  • Porfimer sodium & steroid
  • Eluting electrodes

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY APPLICATION

  • Infectious Diseases
  • Cardiovascular Diseases
  • Psychiatric Disorders
  • Respiratory Disorders

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Combination Drugs Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Combination Drugs Diagnostic Market Snippet by Product Type
    • 2.1.2. Combination Drugs Diagnostic Market Snippet by Application
    • 2.1.3. Combination Drugs Diagnostic Market Snippet by Country
    • 2.1.4. Combination Drugs Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Combination Drugs Diagnostic Key Market Trends

  • 3.1. Combination Drugs Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Combination Drugs Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Combination Drugs Diagnostic Market Opportunities
  • 3.4. Combination Drugs Diagnostic Market Future Trends

4. Combination Drugs Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Combination Drugs Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Combination Drugs Diagnostic Market Landscape

  • 6.1. Combination Drugs Diagnostic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Combination Drugs Diagnostic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Ultrasound
    • 7.1.3. Antimicrobial catheters
    • 7.1.4. Cardiovascular catheters
    • 7.1.5. Urological catheters
    • 7.1.6. Oximetry catheters
    • 7.1.7. Bone graft substitutes
    • 7.1.8. Porfimer sodium & steroid
    • 7.1.9. Eluting electrodes

8. Combination Drugs Diagnostic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Psychiatric Disorders
    • 8.1.5. Respiratory Disorders

9. Combination Drugs Diagnostic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Combination Drugs Diagnostic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Combination Drugs Diagnostic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Combination Drugs Diagnostic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Combination Drugs Diagnostic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Combination Drugs Diagnostic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Combination Drugs Diagnostic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Roche
    • 10.2.3. Novartis International AG
    • 10.2.4. GlaxoSmithKline plc.
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Sanofi
    • 10.2.7. Bristol-Myers Squibb Company
    • 10.2.8. Johnson & Johnson
    • 10.2.9. Eli Lilly and Company
    • 10.2.10. Gilead Sciences, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Combination Drugs Diagnostic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Combination Drugs Diagnostic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Combination Drugs Diagnostic Market, by Application 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Combination Drugs Diagnostic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Combination Drugs Diagnostic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Europe Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Latin America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Germany Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE India Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Brazil Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)